$CLRI
Cleartronic, Inc. Stock $clri

$clri Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000109181823000149 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$554.3K	$560.4K	$538.1K
YoY Change	13.2%	4.14%	30.02%
Cost Of Revenue	$86.42K	$80.71K	$89.94K
YoY Change	0.42%	-10.26%	38.84%
Gross Profit	$467.8K	$479.7K	$448.2K
YoY Change	15.92%	7.03%	28.38%
Gross Profit Margin	84.41%	85.6%	83.29%
Selling, General & Admin	$509.7K	$468.4K	$281.1K
YoY Change	86.98%	66.62%	10.79%
% of Gross Profit	108.94%	97.65%	62.73%
Research & Development	$1.500K	$2.000K	$46.92K
YoY Change	-97.57%	-95.74%	-2.82%
% of Gross Profit	0.32%	0.42%	10.47%
Depreciation & Amortization	$1.360K	$1.332K	$959.00
YoY Change	36.0%	38.89%	84.07%
% of Gross Profit	0.29%	0.28%	0.21%
Operating Expenses	$512.5K	$471.7K	$329.0K
YoY Change	52.86%	43.38%	8.75%
Operating Profit	-$44.67K	$7.934K	$119.2K
YoY Change	-165.4%	-93.34%	155.99%
Interest Expense	$690.00	$690.00	-$130.00
YoY Change	-630.77%	-630.77%	-150.0%
% of Operating Profit		8.7%	-0.11%
Other Income/Expense, Net		$686.00	$47.66K
YoY Change		-98.56%	154.94%
Pretax Income	-$43.98K	$8.620K	$166.8K
YoY Change	-164.52%	-94.83%	155.69%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$54.32K	$8.620K	$166.8K
YoY Change	-193.93%	-94.83%	155.69%
Net Earnings / Revenue	-9.8%	1.54%	31.0%
Basic Earnings Per Share		$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	228.9M shares	228.8M shares	228.1M shares
Diluted Shares Outstanding		599.4M shares	599.5M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$517.0K	$426.5K	$227.1K
YoY Change	10.42%	87.84%	-24.84%
Cash & Equivalents	$517.0K	$426.5K	$227.0K
Short-Term Investments
Other Short-Term Assets	$68.52K	$91.33K	$26.73K
YoY Change	27.81%	241.68%	-69.82%
Inventory	$21.91K	$20.43K	$13.09K
Prepaid Expenses	$30.27K	$40.33K
Receivables	$545.6K	$609.1K	$460.9K
Other Receivables	$2.730K	$2.030K	$0.00
Total Short-Term Assets	$1.156M	$1.149M	$727.8K
YoY Change	6.92%	57.94%	15.52%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.53K	$17.88K	$13.72K
YoY Change	9.14%	30.38%	51.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$144.1K	$107.1K	$67.02K
YoY Change	110.56%	59.78%	123.1%
TOTAL ASSETS
Total Short-Term Assets	$1.156M	$1.149M	$727.8K
Total Long-Term Assets	$144.1K	$107.1K	$67.02K
Total Assets	$1.300M	$1.256M	$794.8K
YoY Change	13.09%	58.09%	20.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$85.86K	$87.16K	$115.9K
YoY Change	14.15%	-24.76%	-41.55%
Accrued Expenses	$24.58K	$23.91K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.216M	$1.112M	$790.7K
YoY Change	11.83%	40.64%	-31.9%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$78.61K	$95.29K	$123.6K
YoY Change	-30.62%	-22.9%	1626.26%
Total Long-Term Liabilities	$78.61K	$95.29K	$123.6K
YoY Change	-30.62%	-22.91%	8.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.216M	$1.112M	$790.7K
Total Long-Term Liabilities	$78.61K	$95.29K	$123.6K
Total Liabilities	$1.295M	$1.207M	$914.3K
YoY Change	7.82%	32.05%	-28.29%
SHAREHOLDERS EQUITY
Retained Earnings	-$15.24M	-$15.19M	-$15.36M
YoY Change	-0.37%	-1.1%	-3.29%
Common Stock	$2.291K	$2.289K	$2.281K
YoY Change	0.44%	0.35%	0.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.177K	$49.15K	-$119.6K
YoY Change
Total Liabilities & Shareholders Equity	$1.300M	$1.256M	$794.8K
YoY Change	13.09%	58.09%	20.42%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$54.32K	$8.620K	$166.8K
YoY Change	-193.93%	-94.83%	155.69%
Depreciation, Depletion And Amortization	$1.360K	$1.332K	$959.00
YoY Change	36.0%	38.89%	84.07%
Cash From Operating Activities	$134.8K	$42.87K	-$156.7K
YoY Change	-44.64%	-127.35%	-178.77%
INVESTING ACTIVITIES
Capital Expenditures	$44.37K	$2.120K	$0.00
YoY Change	-1933.47%		-100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change
Cash From Investing Activities	-$44.37K	-$2.120K	$0.00
YoY Change	1733.47%		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000	0.000
YoY Change
NET CHANGE
Cash From Operating Activities	134.8K	42.87K	-156.7K
Cash From Investing Activities	-44.37K	-2.120K	0.000
Cash From Financing Activities	0.000	0.000	0.000
Net Change In Cash	90.46K	40.75K	-156.7K
YoY Change	-62.48%	-126.0%	-179.59%
FREE CASH FLOW
Cash From Operating Activities	$134.8K	$42.87K	-$156.7K
Capital Expenditures	$44.37K	$2.120K	$0.00
Free Cash Flow	$90.46K	$40.75K	-$156.7K
YoY Change	-63.22%	-126.0%	-177.96%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001362516
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2022Q3	clri	Interest Receivable Related Party Current InterestReceivableRelatedPartyCurrent		usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2023Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
	clri	Gain On Settlementand Reversal Of Accounts Payable GainOnSettlementandReversalOfAccountsPayable		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
	us-gaap	Increase Decrease In Notes Receivable Related Parties Current IncreaseDecreaseInNotesReceivableRelatedPartiesCurrent		usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
	clri	Cancellationof Shares Of Common Stock CancellationofSharesOfCommonStock		usd
	clri	Rightofuse Asset Obtained In Exchange For Operating Lease Liabilities RightofuseAssetObtainedInExchangeForOperatingLeaseLiabilities		usd
	clri	Series C Convertible Preferred Shares Exchanged For Common Stock SeriesCConvertiblePreferredSharesExchangedForCommonStock		usd
CY2023Q2	clri	Series C Convertible Preferred Shares Exchanged For Common Stock SeriesCConvertiblePreferredSharesExchangedForCommonStock		usd
	clri	Share Cancellation ShareCancellation		usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability		usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent		pure
CY2022	clri	Amorization On Rightofuse Opeating Lease Asset AmorizationOnRightofuseOpeatingLeaseAsset		usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments		usd
CY2022	us-gaap	Lease Cost LeaseCost		usd
CY2022	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse		usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	CLEARTRONIC, INC.
	dei	Entity File Number EntityFileNumber	000-55329
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	65-0958798
	dei	Entity Address Address Line1 EntityAddressAddressLine1	28050 US Hwy 19N
	dei	Entity Address City Or Town EntityAddressCityOrTown	Clearwater
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33761
	dei	City Area Code CityAreaCode	813
	dei	Local Phone Number LocalPhoneNumber	289-7620
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common stock
	dei	Trading Symbol TradingSymbol	CLRI
	dei	Security Exchange Name SecurityExchangeName	NONE
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	228880695	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	426498	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	468167	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	609113	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	538030	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	20429	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	21097	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	91327	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	53611	usd
CY2023Q2	clri	Interest Receivable Related Party Current InterestReceivableRelatedPartyCurrent	2029	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	1149396	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	1080905	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17883	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15142	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	35897	usd
CY2023Q2	clri	Due From Related Party DueFromRelatedParty	53302	usd
CY2022Q3	clri	Due From Related Party DueFromRelatedParty	53302	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	53302	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	53302	usd
CY2023Q2	us-gaap	Assets Assets	1256478	usd
CY2022Q3	us-gaap	Assets Assets	1149349	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	87159	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	75217	usd
CY2023Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1000974	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1012211	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	23905	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1112038	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1087428	usd
CY2023Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	82400	usd
CY2022Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	113300	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12886	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	95286	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	113300	usd
CY2023Q2	us-gaap	Liabilities Liabilities	1207324	usd
CY2022Q3	us-gaap	Liabilities Liabilities	1200728	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	228880695	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	228880695	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	228120695	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	228120695	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	2289	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	2281	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15240106	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15240112	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15193315	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15293848	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	49154	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-51379	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1256478	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1149349	usd
CY2023Q2	us-gaap	Revenues Revenues	560374	usd
CY2022Q2	us-gaap	Revenues Revenues	538102	usd
	us-gaap	Revenues Revenues	1577692	usd
	us-gaap	Revenues Revenues	1527910	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	80710	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	89938	usd
	us-gaap	Cost Of Revenue CostOfRevenue	229747	usd
	us-gaap	Cost Of Revenue CostOfRevenue	248074	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	479664	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	448164	usd
	us-gaap	Gross Profit GrossProfit	1347945	usd
	us-gaap	Gross Profit GrossProfit	1279836	usd
CY2023Q2	us-gaap	Selling Expense SellingExpense	114475	usd
CY2022Q2	us-gaap	Selling Expense SellingExpense	65032	usd
	us-gaap	Selling Expense SellingExpense	249137	usd
	us-gaap	Selling Expense SellingExpense	164575	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	353923	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	263012	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	970679	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	824042	usd
CY2023Q2	us-gaap	Depreciation Depreciation	1332	usd
CY2022Q2	us-gaap	Depreciation Depreciation	959	usd
	us-gaap	Depreciation Depreciation	3694	usd
	us-gaap	Depreciation Depreciation	2733	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	25815	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3153	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	471730	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	329003	usd
	us-gaap	Operating Expenses OperatingExpenses	1249325	usd
	us-gaap	Operating Expenses OperatingExpenses	994503	usd
CY2022Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	47792	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	47792	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	686	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-133	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1913	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-402	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	686	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	47659	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1913	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	47390	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8620	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	166820	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	100533	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	332723	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	8620	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	166820	usd
	us-gaap	Profit Loss ProfitLoss	100533	usd
	us-gaap	Profit Loss ProfitLoss	332723	usd
CY2023Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	10231	usd
CY2022Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	10232	usd
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	30694	usd
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	30695	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1611	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	156588	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	69839	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	302028	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228826849	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228120695	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228745310	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228280177	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	599428484	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	599482330	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	599346945	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	599641812	shares
	us-gaap	Net Income Loss NetIncomeLoss	100533	usd
	us-gaap	Net Income Loss NetIncomeLoss	332723	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3694	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2733	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	11966	usd
	clri	Gain On Settlementand Reversal Of Accounts Payable GainOnSettlementandReversalOfAccountsPayable	47792	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	71083	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	148650	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-668	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1564	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	39745	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-20658	usd
	us-gaap	Increase Decrease In Notes Receivable Related Parties Current IncreaseDecreaseInNotesReceivableRelatedPartiesCurrent	8501	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	11942	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3687	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-42137	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-333320	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-11072	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-35234	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-168898	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6435	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5058	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6435	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5058	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-41669	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-173956	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	468167	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	401001	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	426498	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	227045	usd
	us-gaap	Interest Paid Net InterestPaidNet	117	usd
	us-gaap	Interest Paid Net InterestPaidNet	402	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	400	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	690	usd
	clri	Cancellationof Shares Of Common Stock CancellationofSharesOfCommonStock	8	usd
	clri	Rightofuse Asset Obtained In Exchange For Operating Lease Liabilities RightofuseAssetObtainedInExchangeForOperatingLeaseLiabilities	47863	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-51379	usd
	us-gaap	Profit Loss ProfitLoss	100533	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	49154	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	40534	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	8620	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	49154	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-452274	usd
	us-gaap	Profit Loss ProfitLoss	332723	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-119551	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-286371	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	166820	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-119551	usd
CY2022Q3	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	38250	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	40327	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	15361	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1611	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	156588	usd
CY2023Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	10231	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_z59dhlyBWNWi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zxuuD370V3Rc">USE OF ESTIMATES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing the financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the balance sheet and operations for the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although these estimates are based on managements knowledge of current events and actions it may undertake in the future, they may ultimately differ from actual results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant estimates include the assumptions used in valuation of deferred tax assets, estimated useful life of property and equipment, valuation of inventory and allowance for doubtful accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	18000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	18000	usd
CY2023Q2	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	51000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_zvCEAfUdMis1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zY2PnqaiB4Oj">CONCENTRATION OF CREDIT RISK</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company currently maintains cash balances at one FDIC-insured banking institution. Deposits held in non interest-bearing transaction accounts are insured up to a maximum of $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_c20230630_pp0p0" title="Cash balance insured by FDIC per financial institution">250,000</span> at all FDIC-insured institutions. As of June 30, 2023 and September 30, 2022, the Company had $<span id="xdx_90E_ecustom--AmountOfFdicInsuranceLimits_c20221001__20230630_pp0p0" title="Amount of FDIC insurance limits">139,559</span> and $<span id="xdx_909_ecustom--AmountOfFdicInsuranceLimits_c20211001__20220930_pp0p0" title="Amount of FDIC insurance limits">208,135</span>, respectively, in excess of FDIC insurance limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
	clri	Amount Of Fdic Insurance Limits AmountOfFdicInsuranceLimits	139559	usd
CY2022	clri	Amount Of Fdic Insurance Limits AmountOfFdicInsuranceLimits	208135	usd
CY2023Q2	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	2000	usd
CY2022Q2	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	46923	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	25815	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	143199	usd
CY2023Q2	clri	Deferred Subscriber Costs Net Balance DeferredSubscriberCostsNetBalance	51000	usd
CY2022Q3	clri	Deferred Subscriber Costs Net Balance DeferredSubscriberCostsNetBalance	38250	usd
CY2023Q2	us-gaap	Deferred Revenue DeferredRevenue	1083374	usd
CY2022Q3	us-gaap	Deferred Revenue DeferredRevenue	1125511	usd
CY2023Q2	us-gaap	Regulated Operating Revenue RegulatedOperatingRevenue	560374	usd
CY2022Q2	us-gaap	Regulated Operating Revenue RegulatedOperatingRevenue	538102	usd
	us-gaap	Regulated Operating Revenue RegulatedOperatingRevenue	1577692	usd
	us-gaap	Regulated Operating Revenue RegulatedOperatingRevenue	1527910	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1125511	usd
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1131796	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1535555	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2011278	usd
	us-gaap	Contract With Customer Asset Allowance For Credit Loss Writeoff ContractWithCustomerAssetAllowanceForCreditLossWriteoff	1577692	usd
CY2022	us-gaap	Contract With Customer Asset Allowance For Credit Loss Writeoff ContractWithCustomerAssetAllowanceForCreditLossWriteoff	2017563	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1083374	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1125511	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1611	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	156588	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228826849	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228120695	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	69839	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	302028	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228745310	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228280177	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	10232	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	8620	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	166820	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228826849	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228120695	shares
CY2023Q2	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	370601635	shares
CY2022Q2	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	371361635	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	599428484	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	599482330	shares
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	69839	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	302028	usd
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	30694	usd
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	30695	usd
	us-gaap	Profit Loss ProfitLoss	100533	usd
	us-gaap	Profit Loss ProfitLoss	332723	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228745310	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228280177	shares
	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	370601635	shares
	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	371361635	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	599346945	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	599641812	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	20429	usd
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	0	usd
CY2022Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	21097	usd
CY2022Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	0	usd
CY2022Q3	us-gaap	Cumulative Dividends CumulativeDividends	165035	usd
	clri	Number Of Common Stock Shares Issued From Conversion Of Series C Preferred Stock Converted NumberOfCommonStockSharesIssuedFromConversionOfSeriesCPreferredStockConverted	760000	shares
CY2023Q2	us-gaap	Advertising Expense AdvertisingExpense	46693	usd
CY2022Q2	us-gaap	Advertising Expense AdvertisingExpense	21223	usd
	us-gaap	Advertising Expense AdvertisingExpense	77460	usd
	us-gaap	Advertising Expense AdvertisingExpense	33044	usd
CY2023Q1	us-gaap	Area Of Land AreaOfLand	1145	sqft
	us-gaap	Payments For Rent PaymentsForRent	2134	usd
	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	2198	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	35897	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	36791	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08	pure
	clri	Amorization On Rightofuse Opeating Lease Asset AmorizationOnRightofuseOpeatingLeaseAsset	11966	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1731	usd
	us-gaap	Lease Cost LeaseCost	13697	usd
	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	12804	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	47863	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	6402	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	26184	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	6594	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	39180	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2389	usd
CY2023Q2	clri	Present Value Of Operating Lease Liability PresentValueOfOperatingLeaseLiability	36791	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	23905	usd
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	12886	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	28040	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	21605	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10157	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6463	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17883	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15142	usd
CY2023Q2	us-gaap	Depreciation Depreciation	1332	usd
CY2022Q2	us-gaap	Depreciation Depreciation	959	usd
	us-gaap	Depreciation Depreciation	3694	usd
	us-gaap	Depreciation Depreciation	2733	usd
CY2023Q2	us-gaap	Cumulative Dividends CumulativeDividends	195837	usd
CY2023Q2	clri	Rent Expense RentExpense	0	usd
CY2022Q2	clri	Rent Expense RentExpense	7029	usd
	clri	Rent Expense RentExpense	2343	usd
	clri	Rent Expense RentExpense	19944	usd
CY2022Q4	clri	Advanced Amounts AdvancedAmounts	53302	usd
CY2022Q4	clri	Area Of Leased Facility AreaOfLeasedFacility	1145	sqft
CY2022Q4	clri	Monthly Rental Cost MonthlyRentalCost	2134	usd
CY2022Q4	clri	Monthly Rent MonthlyRent	2198	usd
CY2021Q4	clri	Area Of Leased Facility AreaOfLeasedFacility	2000	sqft
CY2021Q4	clri	Monthly Rental Cost MonthlyRentalCost	2200	usd
CY2021Q4	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2022-11-30
	us-gaap	Royalty Expense RoyaltyExpense	7640	usd
	us-gaap	Royalty Expense RoyaltyExpense	4000	usd

Files In Submission

Name	View Source	Status
clri-20230630_def.xml	Edgar Link	unprocessable
clri-20230630_cal.xml	Edgar Link	unprocessable
0001091818-23-000149-index-headers.html	Edgar Link	pending
0001091818-23-000149-index.html	Edgar Link	pending
0001091818-23-000149.txt	Edgar Link	pending
0001091818-23-000149-xbrl.zip	Edgar Link	pending
clri-20230630.htm	Edgar Link	pending
clri-20230630.xsd	Edgar Link	pending
ex311.htm	Edgar Link	pending
ex312.htm	Edgar Link	pending
ex321.htm	Edgar Link	pending
ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
clri-20230630_lab.xml	Edgar Link	unprocessable
clri-20230630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
clri-20230630_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLRI
Cleartronic, Inc. Stock $clri

2023 Q3 Form 10-Q Financial Statement

#000109181823000149 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRI Cleartronic, Inc. Stock $clri

2023 Q3 Form 10-Q Financial Statement

#000109181823000149 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRI
Cleartronic, Inc. Stock $clri